3SOF

 

MarketWatch
Market Pulse: Cardiac Science gets OK to market defibrillators in Japan
Thursday August 25, 5:21 pm ET
By Gabriel Madway


SAN FRANCISCO (MarketWatch) -- Cardiac Science Inc. said after Thursday's closing bell that it has received approval from the Japanese government to market a biphasic version of the company's automatic public-access defibrillators in Japan. The product will be marketed under the CardioLife brand name by Nihon Kohden Corp. . Cardiac Science is based in Irvine, Calif.

AP
Japan OKs Cardiac Science Defibrillator
Thursday August 25, 6:47 pm ET 
Japanese Regulators Approve More Advanced Version of Cardiac Science Defibrillator


IRVINE, Calif. (AP) -- Cardiac Science Inc. said Thursday that the Japanese government approved its updated automatic public-access defibrillator, or AED, ending a review process that stretched out over two years.


Shares of the maker of emergency defibrillators and related medical devices jumped 9.7 percent to $1.13 in after-hours trading. Its stock closed up 1 cent at $1.03 in regular session on the Nasdaq.

Cardiac Science has sold an earlier version of the defibrillator through Nihon Kohden Corp. since 2002, but the lengthy review of the more advanced product allowed a competitor with an approved product to capture some of its market share, the company said.

The firm's 2005 shipments to Japan were sharply lower than 2004 shipments as a result.

The "biphasic" product -- which uses a more sophisticated current flow -- will be sold under the CardioLife brand by Japan's largest medical device maker, Nihon Kohden.

"The product is now ready for shipment and we are confident that with our biphasic version AED will allow us to regain our previous momentum," said Chairman and Chief Executive Raymond W. Cohen, in a statement.

 


TradingMarkets.com
TradingMarkets' 10 Stocks You Need To Know About Today
Friday August 26, 12:09 pm ET
By TradingMarkets Research


Novell (NasdaqNM:NOVL - News) beat by a penny; quarterly profit, however, fell on higher tax and restructuring costs.


Hewlett Packard (NYSE:HPQ - News) said it would reserve an additional $4 billion for stock buybacks.

Merck (NYSE:MRK - News) said it may settle some of the 5,000 pending Vioxx related lawsuits.

Pixar (NYSE:PIXR - News) is being investigated by the SEC over heavy returns of the film "The Incredibles." PIXR cited the returns as the reason the company missed Q2 estimates.

Petco (NasdaqNM:PETC - News) was in-line and guided lower. The company was downgraded to neutral at JP Morgan.

Cardiac Science (NasdaqNM:DFIB - News) received permission to market its automatic public access defibrillators in Japan.

Omnivision (NasdaqNM:OVTI - News) missed by 0.02.

Business Week reports AtheroGenics (NasdaqNM:AGIX - News) may be a buyout candidate, according to John McCamant of the Medical Technology Stock Letter.

Renovis (NasdaqNM:RNVS - News) said Phase III trials of Ren 1654 did not meet primary endpoints and that it is discontinuing development.

Seagate (NYSE:STX - News) was downgraded to equalweight at Morgan Stanley.

The World's Largest Site For Traders -- www.tradingmarkets.com. Visit us now.

Press Release Source: Winland Electronics, Inc.


Winland Electronics, Inc. Announces Agreement With Cardiac Science
Thursday August 25, 9:12 am ET 
Winland solidifies relationship with fourth fastest growing technology company in North America with two-year agreement and initial orders totaling over $1.8 million


MANKATO, Minn., Aug. 25 /PRNewswire-FirstCall/ -- Winland Electronics, Inc., (Amex: WEX - News), a leading designer and manufacturer of custom electronic control products and systems, today announced it signed a two-year purchase and supply agreement with Cardiac Science, Inc., (Nasdaq: DFIB - News) a leading manufacturer of life-saving public-access Automated External Defibrillators (AEDs) and provider of comprehensive AED/CPR training and AED program management services.



Under terms of the two-year agreement, which is effective through June, 2007, Winland will build printed circuit board assemblies (PCBAs) for Cardiac Science's new hospital defibrillator and its AED training device, which is used to train and educate customers that purchase AEDs from Cardiac Science. Winland has received initial orders valued at over $1.8 million, and has already shipped approximately $600,000 in products, with the balance of the initial order scheduled through early 2006.

Cardiac Science's Vice President of Manufacturing Mike Kenison commenting on the agreement said, "We evaluated numerous vendors and we selected Winland not only because of Winland's manufacturing and design expertise but just as importantly on their proven track record of delivering on their commitments."

Cardiac Science was recently ranked as the fourth fastest-growing technology company in North America on the 2004 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America.

Dale A. Nordquist, Winland's Senior Vice President of Sales & Marketing commented, "We are excited to be working with Cardiac Science in the development of its life-saving technology and look forward to a long term relationship. This relationship is a validation of our entrance into the Medical Device market and evidence of our ability to bring our product realization expertise to this important market."

About Cardiac Science

Cardiac Science, with operations in Orange County, CA, Minneapolis, MN, Manchester, England and Copenhagen, Denmark, develops, manufactures and markets Powerheart®-brand automatic public-access defibrillators (AEDs). In the U.S., Cardiac Science products are sold to corporations, police and fire departments, state and local municipalities, the federal government and schools by its 55-person direct sales force, and certain national and local distributors. Internationally, Cardiac Science products are sold direct in the United Kingdom and by independent distributors in over 60 countries. Cardiac Science also manufactures its AED products on a private label OEM basis for other leading medical companies such as Quinton Cardiology Systems, Nihon Kohden (Japan) and GE Healthcare. For more information, please visit http://www.cardiacscience.com or contact Cardiac Science at (949) 797-3800.

About Winland Electronics

Winland Electronics is an electronic manufacturing services (EMS) company, providing product development and manufacturing expertise and innovation for more than 20 years. Winland also markets proprietary products for the security/industrial marketplace. Winland's product development offering includes program management, analog circuit design, digital circuit design, printed circuit board design and embedded software design. Winland differentiates itself from the contract manufacturer competition with its integrated product development and manufacturing services to offer end-to-end product launch capability, including design for manufacturability, design for testability, transition to manufacturing and order fulfillment. Winland's core competency is delivering time-to-market through superior program management, experience, integrated development processes, and cross-functional teams. Winland Electronics is based in Mankato, MN. For more information, visit http://www.winland.com.

Cautionary Statements

Certain statements contained in this press release and other written and oral statements made from time to time by the company do not relate strictly to historical or current facts. As such, they are considered forward-looking statements, which provide current expectations or forecasts of future events. The statements included in this release with respect to (i) the initial orders from Cardiac Science and the scheduling of those orders through early 2006 are forward looking statements. These statements involve a variety of risks and uncertainties, known and unknown, including, among others, the risks that (i) Cardiac Science may cancel purchase orders or fail to submit any additional purchase orders, (ii) we may encounter unexpected delays or design or manufacturing problems in connection with PCBA's manufactured for Cardiac Science that result in Cardiac Science rejecting shipments or canceling purchase orders, (iii) Cardiac Science and other customers may cease to do business with us or demand pricing that reduces our profitability as a condition to retaining the business; (iii) costs of production may exceed current estimates. Consequently, no forward-looking statement can be guaranteed and actual results may vary materially.


     Lorin E. Krueger
     Chief Executive Officer
     (507) 625-7231
     http://www.winland.com/

     Brett Maas or Cameron Donahue
     Hayden Communications
     (843) 272-4653




--------------------------------------------------------------------------------
Source: Winland Electronics, Inc.

Could be this thing is ready to make a run.
Big volume Friday and indicators pointing north.
Stochastic is bullish, with a bearish MACD,which is about to change,pointing
north and about to cross center.
Support @ $1.13...1.10...1.06
Resistance @ $1.19...1.31...1.36

Technicals
Close Above the 50-day EMA
Close Above the 13-day EMA
Most Actives
Percentage Gainer

Last Price Quote is:
7.60%above 13-day EMA
7.32%above 50-day EMA
RS Rating: 84 

Fundamentals
Key Data:
Market Cap (M): $98.84   
Next Earnings: 10/26/2005
Last Analyst Rating: Sector Perform

Cardiac Science Corporation (NASDAQ: CSCX) is a global leader in developing, manufacturing and marketing diagnostic and therapeutic cardiology products and services that protect hearts and save lives.

Formed by the merger of Cardiac Science, Inc. and Quinton Cardiology Systems, Inc. on September 1, 2005, the company employs more than 550 people worldwide. Headquartered near Seattle, WA, the company also has operations in California, Wisconsin, China, Denmark and the United Kingdom.

The strategic benefits of the merger are significant — including substantial operational savings, stronger distribution networks, enhanced customer service and greater technology capabilities to support cutting-edge product development.

Three Trusted Brands, One New Company.
By leveraging the market leadership of its predecessor companies and their established brands — Burdick®, Powerheart®, and Quinton® — Cardiac Science Corporation is uniquely positioned to effectively address both established and emerging cardiology market segments.

A Broad Range of Cardiology Products and Services.
From individual devices designed to identify the early stages of heart disease—such as Electrocardiographs, Cardiac Stress Testing Systems, and Holter Monitors—to sophisticated systems that enable Cardiac Rehabilitation and Cardiology Data Management, as well as life-saving, innovative and patented automated external defibrillators (AEDs) for both medical and non-medical markets, Cardiac Science Corporation offers solutions across the entire continuum of cardiac care.

A variety of related products and supplies, as well as superior customer and technical support through a comprehensive portfolio of training, maintenance and service programs, are also available to accommodate diverse budgets and needs.

 DFIB merging with QUIN..........The Chart